BD plans split from life science business to fuel medtech investment

Summary

The article discusses BD's strategic separation of its biosciences and diagnostics unit to focus on high-growth areas within its MedTech segment, aligning with the key concept. BD is headquartered in Franklin Lakes, New Jersey, with potential connections to Agilent Technologies through acquisitions or industry relevance.